Further to the announcement of 14 September 2023, the Board of Hipgnosis Songs Fund Limited has completed the sale of c.20,000 songs (the “Songs”) for a gross consideration of $23.1 million, representing approximately 1% by value of the Company’s investment portfolio. 

The Company is pleased to announce the appointment of Singer Capital Markets as sole corporate broker and financial adviser and Shot Tower Capital, LLC as lead adviser to conduct due diligence on the Company’s assets as part of its strategic review. 

The Company will announce its financial results for the six months to 30 September 2023 on Tuesday 19 December 2023.